Provided by Tiger Trade Technology Pte. Ltd.

Camp4 Therapeutics Corp.

3.94
-0.0250-0.63%
Volume:67.36K
Turnover:259.48K
Market Cap:246.93M
PE:-1.77
High:3.95
Open:3.85
Low:3.70
Close:3.96
52wk High:7.75
52wk Low:1.41
Shares:62.75M
Float Shares:38.06M
Volume Ratio:0.64
T/O Rate:0.18%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.2250
EPS(LYR):-2.6500
ROE:-545.85%
ROA:-45.25%
PB:-356.33
PE(LYR):-1.48

Loading ...

Canadian GoldCamps Moves Ahead with Québec Gold Projects and NI 43-101 Work

TIPRANKS
·
Apr 15

CAMP4 Therapeutics Initiated at Buy by Rodman & Renshaw

Dow Jones
·
Apr 14

Camp4 Therapeutics initiated with a Buy at Rodman & Renshaw

TIPRANKS
·
Apr 14

Camp4 Therapeutics files Form 3 for director Michael F. MacLean

Reuters
·
Apr 04

Camp4 Therapeutics price target raised to $9 from $8 at Leerink

TIPRANKS
·
Apr 02

Canadian GoldCamps Secures Option to Acquire Majority Stake in Stelmine’s Québec Gold Projects

TIPRANKS
·
Apr 02

Open-Sourcing to Empower, AI to Lead Medicine: "SurgMotion", the Best-in-class Surgical Video Foundation Model, Officially Launched

prnewswire
·
Mar 25

CAMP4 Therapeutics Adds Veteran CFO MacLean to Board

TIPRANKS
·
Mar 24

Camp4 appoints Michael MacLean to board, expands board to nine directors

Reuters
·
Mar 24

Camp4 Appoints Michael Maclean to Its Board of Directors

THOMSON REUTERS
·
Mar 24

Press Release: CAMP4 Appoints Michael MacLean to its Board of Directors

Dow Jones
·
Mar 24

CAMP4 Therapeutics Up Over 62%, on Pace for Largest Percent Increase Since December 2024 -- Data Talk

Dow Jones
·
Mar 10

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 12:38 PM

Reuters
·
Mar 10

Camp4 Therapeutics to Present at Stifel CNS Forum

Reuters
·
Mar 07

Analysts Offer Insights on Healthcare Companies: Tango Therapeutics (TNGX), Cooper Co (COO) and CAMP4 Therapeutics Corporation (CAMP)

TIPRANKS
·
Mar 06

CAMP4 Therapeutics Corporation (CAMP) Receives a Buy from Piper Sandler

TIPRANKS
·
Mar 06

CAMP4 Highlights 2025 Results and SYNGAP1 Program Progress

TIPRANKS
·
Mar 06

Camp4 Therapeutics Q4 EPS $(0.87) Misses $(0.30) Estimate, Sales $348.000K Miss $538.000K Estimate

Benzinga Earnings
·
Mar 06

Camp4 Therapeutics FY 2025 research and collaboration revenue rises 436.5% to USD 3.5 million

Reuters
·
Mar 06

CAMP4 FY 2025 net loss USD 80.4 million widens 55.2%

Reuters
·
Mar 06